Volume 4, Issue 2 (9-2017)                   nbr 2017, 4(2): 181-188 | Back to browse issues page

XML Persian Abstract Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Tayanloo A, Zare1 S, Karimzadeh-Bardei L, Hoseini S. Effect of Urtica dioica hydroalcoholic extract on liver inflammatory factors in polycystic ovarian syndrome induced in Wistar rats by estradiol valerate. nbr. 2017; 4 (2) :181-188
URL: http://nbr.khu.ac.ir/article-1-2953-en.html
Urmia University
Abstract:   (2939 Views)
The polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women at childbearing age. Metabolic syndrome is present from 28% to 46% of patients with PCOS. Non-alcoholic fatty liver di-sease (NAFLD) is considered the hepatic expression of metabolic syndrome. In this study Urtica dioica moderator ef-fect on liver function in PCOS rats was examined. 120 adult female Wistar rats were divided into control, PCOS and nettle-treated groups. The PCOS group was injected subcutaneously 2 mg/kg estradiol valerate. After confirmed poly-cystic in ovaries, the experimental group was injected of the nettle extract doses (150,250, 450 mg/kg BW). Then rats were killed and blood samples were evaluated. Data were analyzed using ANOVA one-way and p<0.05 was considered statistically significant. ELISA test showed a decrease in IL-6 level and CRP levels reduced in PCOS rats were treated with various concentrations of nettle. Our results show that nettle due to its antioxidant properties reduce the levels of IL-6 and CRP in nettle extract treated-PCOS compared to the PCOS.
Full-Text [PDF 517 kb]   (1083 Downloads)    
Type of Study: Original Article | Subject: Cell and Molecular Biology
Received: 2017/09/18 | Revised: 2017/09/20 | Accepted: 2017/09/18 | Published: 2017/09/18 | ePublished: 2017/09/18

Add your comments about this article : Your username or Email:

Creative Commons Licence
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2020 All Rights Reserved | Nova Biologica Reperta

Designed & Developed by : Yektaweb